Investing.com - Dice Molecules Holdings LLC reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that was in line with expectations.
Dice Molecules Holdings LLC announced earnings per share of $-0.55 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.60 on revenue of $0.00.
Dice Molecules Holdings LLC shares are down 29.95% from the beginning of the year, still down 33.12% from its 52 week high of $45.99 set on October 11.
Dice Molecules Holdings LLC follows other major Healthcare sector earnings this month
Dice Molecules Holdings LLC's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar